GIM
EMN icon

Glenmede Investment Management’s Eastman Chemical EMN Stock Holding History

Glenmede Investment Management’s Portfolio EMN Stock Details EMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$602K Sell
9,553
-11,182
-54% -$780K ﹤0.01% 860
2025
Q2 		$1.55M Buy
+20,735
New +$1.63M 0.01% 609

Other funds holding EMN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Glenmede Investment Management's EMN Position: Q3 2025 in Review

Glenmede Investment Management reduced its Eastman Chemical (EMN) stake by 54% in Q3 2025, selling an estimated $780K and leaving 9,553 shares worth $602K. The position accounts for ﹤0.01% of the portfolio, ranked #860.

Glenmede Investment Management first reported a position in EMN in Q2 2025 and has held it in 2 quarters since. The position peaked at $1.55M in Q2 2025. 662 funds tracked by Wall St. Rank hold EMN as of Q3 2025.

  • Glenmede Investment Management held 9,553 shares of Eastman Chemical worth $602K as of Q3 2025.
  • Glenmede Investment Management sold 11,182 Eastman Chemical shares in Q3 2025, an estimated $780K.
  • Eastman Chemical made up ﹤0.01% of Glenmede Investment Management's portfolio in Q3 2025, its #860 holding.
  • Glenmede Investment Management first reported a position in Eastman Chemical in Q2 2025 and has held it in 2 quarters since.
  • Glenmede Investment Management's Eastman Chemical position peaked at $1.55M in Q2 2025.
  • 662 funds tracked by Wall St. Rank held Eastman Chemical as of Q3 2025.

Based on Glenmede Investment Management's 13F filing for Q3 2025, filed 13 Nov 2025.